Skip to content

Archives of Pharmacal Research

ISSN 0253-6269

2 papers in the library · 3 citations · publishing 2021-2024

Papers

Sort Most recent Most cited

The novel psychoactive substance 25E-NBOMe induces reward-related behaviors via dopamine D1 receptor signaling in male rodents

Archives of Pharmacal Research April 1, 2024 Young-Jung Kim, Wun-A Kook, Shi-Xun Ma et al. 3 citations

Novel psychoactive substances (NPSs) are new psychotropic drugs designed to evade substance regulatory policies. 25E-NBOMe (2-(4-ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine) has recently been identified as an NPS, and its recreational misuse has been reported to be rapidly increasing. However, the psychopharmacological effects and mechanisms of 25E-NBOMe have not been studied. We...

DOI: 10.1007/s12272-024-01491-4 (opens in new tab) Full text (opens in new tab) 25e-nbome Novel psychoactive substance Reward Dopamine d1 receptor +1

Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists.

Archives of Pharmacal Research April 2021 Eun Yong Chung, Hye Jin Cha, Hyun Kyu Min et al.

Over the last decade, new psychoactive substances (NPS) have continuously been the focus of the international society since their emergence on the illicit drug market. NPS can be classified into six groups including; synthetic cannabinoid receptor agonists (SCRAs), stimulants, opioids, dissociatives, sedatives/hypnotics, and classic hallucinogens with psychoactive effects. These are sold as...

DOI: 10.1007/s12272-021-01326-6 (opens in new tab) Full text (opens in new tab) Adverse effects New psychoactive substances Pharmacology Toxicity